Gliosarcoma – Clinico-pathology, Genetics and a Review of Rare Congenital Cases
Gliosarcoma – Clinico-pathology, Genetics and a Review of Rare Congenital Cases
Published: October 2009
Abstract
Congenital brain tumours are rare. In general, they are preferentially located in the supratentorial compartment, and despite the occurrence of low-grade entities, these tumours are associated with a very poor prognosis. When strictly defined, the most common forms of congenital neoplasia are teratomas and astrocytomas. Among the astrocytomas, all grades (World Health Organization [WHO] I–IV) and many of the different subtypes are represented. This includes the most prognostically worrisome ‘diffusely infiltrating’ astrocytomas. Gliosarcomas are a variant of glioblastoma (i.e. WHO grade IV astrocytoma) that exhibits both malignant astrocytic (i.e. glioblastoma) and mesenchymal (i.e. sarcoma) components. Despite their bi-phasic histology, genetic analyses of adult gliosarcoma cases suggest not only a molecular profile similar to glioblastoma, but also a monoclonal histogenesis for the glial and sarcomatous elements. Congenital gliosarcomas are extremely rare, with only a handful of cases being described in the literature. Not surprisingly, therefore, detailed clinical, pathological and genetic data are limited. However, based on a recent analysis of congenital glioblastomas, congenital gliosarcomas may constitute an entity that is genetically and prognostically distinct from adult cases.
Congenital brain tumours are infrequent and account for approximately 1–4% of all paediatric cases.1 One to four live births per 100,000 are estimated to be affected by a congenital brain tumour.2,3 The majority of these neoplasms reside in the supratentorial compartment and, as noted by Volpe, the clinical manifestations of congenital brain tumours usually involve one or more of four typical syndromes.4 These syndromes are predicated on:
- macrocrania;
- hydrocephalus;
- focal neurologicsl deficit(s); and
- acute intracranial haemorrhage.
Although neuroimaging modalities are increasingly identifying cases during foetal development, aggressive surgical and chemo-/radiotherapeutic regimens have yet to significantly alter the dismal prognosis for most of these unfortunate patients.5 As determined by Isaacs in his 2002 review, overall survival is only 28%.2,3
Numerous small case series and larger reviews have been published on the topic of early-onset paediatric brain tumours.2,3,5–13 Ascertaining the frequency of individual congenital tumour types is often made difficult by the inclusion of older children in some analyses (up to 18 months of age in one study).11–13 In particular, these latter studies often underestimate the frequency of teratomas. For example, in Larouche et al.’s review of 1,289 infants less than one year of age, astrocytomas accounted for 30.5% of the cases, while teratomas accounted for only 4.9% of the total.11 Of the larger studies that were more strictly confined to the congenital time period, i.e. all cases less than or equal to two months of age, teratomas and astrocytomas were usually the most frequent tumour type.2,3,5,8 In Isaac’s 2002 analysis of 225 congenital brain tumours, teratomas (44.9%) were by far the most frequent type, followed by astrocytomas (16%) and medulloblastomas (7.6%).2,3 Buetow et al.’s 1990 review of 45 congenital cases included three main categories: 13 astrocytomas (nine grade I–III and four glioblastoma); 12 primitive neuroectodermal tumours (PNETs), four of which were medulloblastoma; and 12 teratomas.8 Finally, the study by Cassart et al. in 2008 of 27 foetal cases included 13 teratomas and four glial tumours (subtype unspecified) without any medulloblastomas/PNETs.5
To read full article please click here
Congenital, gliosarcoma, glioblastoma, neoplasm, astrocytoma, sarcoma, genetics,
- 12 September 2010
- 15 September 2010
- 16 September 2010






